{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:26:12Z","timestamp":1794306372897,"version":"4.9.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Therapy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.reth.2026.101162","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:59:31Z","timestamp":1785369571000},"page":"101162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Host-state biomarkers and clinical factors for stratification and optimization of cell therapy trials in chronic limb-threatening ischemia: A review"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2528-2003","authenticated-orcid":false,"given":"Yusuke","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2388-4542","authenticated-orcid":false,"given":"Edward Hosea","family":"Ntege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2389-1008","authenticated-orcid":false,"given":"Naoki","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1041-1607","authenticated-orcid":false,"given":"Tatsuya","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7550-8050","authenticated-orcid":false,"given":"Hiroshi","family":"Sunami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojiro","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moriyasu","family":"Nakaema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Tokushige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1S","key":"10.1016\/j.reth.2026.101162_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"8","key":"10.1016\/j.reth.2026.101162_bib2","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.reth.2026.101162_bib3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejvs.2021.01.005","article-title":"Outcomes of conservative treatment in patients with chronic limb threatening ischemia: a systematic review and meta-analysis","volume":"62","author":"van Reijen","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2","key":"10.1016\/j.reth.2026.101162_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejvs.2021.04.003","article-title":"Long-term survival and limb salvage in patients with non-revascularisable chronic limb threatening ischemia","volume":"62","author":"Verwer","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"24","key":"10.1016\/j.reth.2026.101162_bib5","doi-asserted-by":"crossref","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American college of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"149","author":"Gornik","year":"2024","journal-title":"Circulation"},{"issue":"36","key":"10.1016\/j.reth.2026.101162_bib6","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.reth.2026.101162_bib7","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jvs.2023.07.020","article-title":"The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes mellitus and a foot ulcer","volume":"78","author":"Fitridge","year":"2023","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.reth.2026.101162_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znag040","article-title":"Development of a standard definition of 'no-option' and 'poor-option' for revascularization in chronic limb-threatening ischemia","volume":"113","author":"Fabiani","year":"2026","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.reth.2026.101162_bib9","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jvs.2025.04.019","article-title":"Patients excluded from BEST-CLI were more likely to undergo a major amputation at a single urban safety net hospital","volume":"82","author":"Schwarz","year":"2025","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1016\/j.reth.2026.101162_bib10","first-page":"257","article-title":"Chronic limb-threatening ischemia: a comprehensive review paper","volume":"14","author":"Daher","year":"2025","journal-title":"Interv Cardiol Clin"},{"issue":"6","key":"10.1016\/j.reth.2026.101162_bib11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/ATVBAHA.124.320195","article-title":"Peripheral artery disease: molecular mechanisms and novel therapies","volume":"44","author":"Athavale","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.reth.2026.101162_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1113982","article-title":"Mesenchymal stem cell-based therapy for non-healing wounds due to chronic limb-threatening ischemia: a review of preclinical and clinical studies","volume":"10","author":"Huerta","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.reth.2026.101162_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.709904","article-title":"Precision medicine enables more TNM-like staging in patients with chronic limb-threatening ischemia","volume":"8","author":"McGinigle","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.reth.2026.101162_bib14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5582\/ddt.2023.01086","article-title":"Which biomarkers predict hard-to-heal diabetic foot ulcers? A scoping review","volume":"17","author":"Qin","year":"2024","journal-title":"Drug Discov Ther"},{"issue":"4","key":"10.1016\/j.reth.2026.101162_bib15","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3390\/biomedicines12040798","article-title":"Narrative review of biological markers in chronic limb-threatening ischemia","volume":"12","author":"Popescu","year":"2024","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.reth.2026.101162_bib16","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1007\/s12015-025-10908-6","article-title":"TNF-\u03b1 pathway activation and altered microRNA expression in peripheral blood-derived endothelial colony-forming cells: insights into diabetes-induced dysfunction","volume":"21","author":"Liu","year":"2025","journal-title":"Stem Cell Rev Rep"},{"issue":"2","key":"10.1016\/j.reth.2026.101162_bib17","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3390\/ijms24021169","article-title":"The role of neutrophils in lower limb peripheral artery disease: state of the art and future perspectives","volume":"24","author":"Buso","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.reth.2026.101162_bib18","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.jvs.2014.07.104","article-title":"The need for improved risk stratification in chronic critical limb ischemia","volume":"60","author":"Chung","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.reth.2026.101162_bib19","article-title":"Predictive factors and models for major adverse cardiovascular and limb events in patients with peripheral arterial disease","author":"Song","year":"2025","journal-title":"Vasa"},{"issue":"4","key":"10.1016\/j.reth.2026.101162_bib20","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jvs.2018.02.028","article-title":"Prognostic value of the society for vascular surgery wound, ischemia, and foot infection (WIfI) classification in patients with no-option chronic limb-threatening ischemia","volume":"68","author":"van Haelst","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.reth.2026.101162_bib21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.reth.2024.06.001","article-title":"Optimizing mesenchymal stem cell extracellular vesicles for chronic wound healing: bioengineering, standardization, and safety","volume":"26","author":"Shimizu","year":"2024","journal-title":"Regen Ther"},{"issue":"1","key":"10.1016\/j.reth.2026.101162_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12929-024-01059-w","article-title":"Unraveling the differential mechanisms of revascularization promoted by MSCs & ECFCs from adipose tissue or umbilical cord in a murine model of critical limb-threatening ischemia","volume":"31","author":"Rojas-Torres","year":"2024","journal-title":"J Biomed Sci"},{"issue":"9331","key":"10.1016\/j.reth.2026.101162_bib23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","article-title":"Therapeutic Angiogenesis using cell transplantation (TACT) study investigators. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial","volume":"360","author":"Tateishi-Yuyama","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.reth.2026.101162_bib24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCINTERVENTIONS.110.958348","article-title":"Intra-arterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA)","volume":"4","author":"Walter","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.reth.2026.101162_bib25","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/mt.2012.52","article-title":"Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial","volume":"20","author":"Powell","year":"2012","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.reth.2026.101162_bib26","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/CIRCINTERVENTIONS.112.968321","article-title":"A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia","volume":"5","author":"Losordo","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.reth.2026.101162_bib27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.114.012913","volume":"131","author":"Teraa","year":"2015","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.reth.2026.101162_bib28","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1253\/circj.CJ-17-0045","article-title":"Autologous bone marrow mononuclear cell implantation and its impact on the outcome of patients with critical limb ischemia: results of a randomized, double-blind, placebo-controlled trial","volume":"81","author":"Pignon","year":"2017","journal-title":"Circ J"},{"issue":"8","key":"10.1016\/j.reth.2026.101162_bib29","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1253\/circj.CJ-17-1220","article-title":"Outcome from a randomized controlled clinical trial: improvement of peripheral arterial disease by Granulocyte colony-stimulating factor-mobilized autologous peripheral-blood-mononuclear cell transplantation (IMPACT)","volume":"82","author":"Horie","year":"2018","journal-title":"Circ J"},{"issue":"2","key":"10.1016\/j.reth.2026.101162_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znad437","article-title":"PACE: randomized, controlled, multicentre, multinational, phase III study of PLX-PAD for critical limb ischemia in patients unsuitable for revascularization: randomized clinical trial","volume":"111","author":"Norgren","year":"2024","journal-title":"Br J Surg"},{"issue":"Suppl 1","key":"10.1016\/j.reth.2026.101162_bib31","first-page":"cvac066","article-title":"Autologous bone marrow mononuclear cells in the treatment of chronic limb-threatening ischemia: a proof-of-concept trial","volume":"118","author":"Chac\u00f3n Quevedo","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.reth.2026.101162_bib32","first-page":"340","article-title":"Cellular therapies in no-option critical limb ischemia: present status and future directions","volume":"18","author":"Kwiatkowski","year":"2022","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"10.1016\/j.reth.2026.101162_bib33","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1007\/s12015-025-11026-z","article-title":"Clinical trial landscape of stem cell therapy for peripheral arterial disease","volume":"22","author":"Liang","year":"2026","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"10.1016\/j.reth.2026.101162_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13287-018-1117-5","article-title":"Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia","volume":"10","author":"Pan","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.reth.2026.101162_bib35","series-title":"Silver Spring (MD): Food and Drug Administration (US)","article-title":"BEST (Biomarkers, EndpointS, and other tools) resource","year":"2016"},{"key":"10.1016\/j.reth.2026.101162_bib36","article-title":"Enrichment strategies for clinical trials to support determination of effectiveness of human drugs and biological products: guidance for industry","year":"2019","journal-title":"Silver Spring (MD): US Food Drug Administration"},{"key":"10.1016\/j.reth.2026.101162_bib37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.avsg.2021.11.008","article-title":"Association between CRP\/Albumin ratio and long-term mortality in patients with chronic limb-threatening ischemia undergoing endovascular therapy below the knee: the ACHILES-BTK registry","volume":"82","author":"Panc","year":"2022","journal-title":"Ann Vasc Surg"},{"issue":"6","key":"10.1016\/j.reth.2026.101162_bib47","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1177\/1358863X241281699","article-title":"Neutrophil-to-lymphocyte ratio as a prognostic biomarker in patients with peripheral artery disease: a systematic review and meta-analysis","volume":"29","author":"Kurniawan","year":"2024","journal-title":"Vasc Med"},{"issue":"2","key":"10.1016\/j.reth.2026.101162_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056745","article-title":"Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in patients with PAOD","volume":"8","author":"Gary","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.reth.2026.101162_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252030","article-title":"Neutrophil-to-lymphocyte ratio associated with an increased risk of mortality in patients with critical limb ischemia","volume":"16","author":"Su","year":"2021","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.reth.2026.101162_bib46","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/CIRCRESAHA.121.319589","article-title":"A missense variant in the IL-6 receptor and protection from peripheral artery disease","volume":"129","author":"Levin","year":"2021","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.reth.2026.101162_bib38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"5","key":"10.1016\/j.reth.2026.101162_bib39","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1253\/circj.CJ-25-0698","article-title":"Non-home discharge after endovascular therapy for chronic limb-threatening ischemia - insights from a Japanese nationwide registry","volume":"90","author":"Hata","year":"2026","journal-title":"Circ J"},{"issue":"3","key":"10.1016\/j.reth.2026.101162_bib52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.15747\/ACNM.2023.15.3.67","article-title":"Role of nutrition in wound healing and nutritional recommendations for promotion of wound healing: a narrative review","volume":"15","author":"Ju","year":"2023","journal-title":"Ann Clin Nutr Metab"},{"key":"10.1016\/j.reth.2026.101162_bib40","series-title":"Guideline on haemoglobin cutoffs to define anaemia in individuals and populations","year":"2024"},{"issue":"5","key":"10.1016\/j.reth.2026.101162_bib41","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1097\/01.ASN.0000061776.60146.02","article-title":"Impact of renal insufficiency on short-term morbidity and mortality after lower extremity revascularization: data from the department of veterans affairs' National Surgical Quality Improvement Program","volume":"14","author":"O'Hare","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"4S","key":"10.1016\/j.reth.2026.101162_bib42","first-page":"S117","article-title":"KDIGO 2024 Clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"issue":"23","key":"10.1016\/j.reth.2026.101162_bib43","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/eurheartj\/ehu163","article-title":"Medial vascular calcification revisited: review and perspectives","volume":"35","author":"Lanzer","year":"2014","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.reth.2026.101162_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1440-1797.2006.00541.x","article-title":"Inflammation in end-stage renal disease: the hidden enemy","volume":"11","author":"Stenvinkel","year":"2006","journal-title":"Nephrology"},{"issue":"1","key":"10.1016\/j.reth.2026.101162_bib53","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jvs.2013.08.003","article-title":"The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI)","volume":"59","author":"Mills","year":"2014","journal-title":"J Vasc Surg"},{"issue":"Suppl 1","key":"10.1016\/j.reth.2026.101162_bib54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/dmrr.2246","article-title":"A systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetes","volume":"28","author":"Game","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"10.1016\/j.reth.2026.101162_bib55","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jvs.2024.11.027","article-title":"Advanced wound, ischemia, and foot infection stage is associated with poor outcomes in the BEST-CLI trial","volume":"81","author":"Siracuse","year":"2025","journal-title":"J Vasc Surg"},{"issue":"6","key":"10.1016\/j.reth.2026.101162_bib56","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A test in context: Lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies","volume":"69","author":"Tsimikas","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.reth.2026.101162_bib57","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1253\/circj.CJ-24-0383","article-title":"Impact of high Lipoprotein(a) levels on delayed wound healing in patients with chronic limb-threatening ischemia after peripheral endovascular therapy","volume":"89","author":"Tomoi","year":"2025","journal-title":"Circ J"},{"issue":"39","key":"10.1016\/j.reth.2026.101162_bib58","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.reth.2026.101162_bib50","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/01.RES.0000209968.66606.10","article-title":"IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation by inhibiting calpain","volume":"98","author":"Bodnar","year":"2006","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.reth.2026.101162_bib59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/CIRCINTERVENTIONS.110.955724","article-title":"Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease","volume":"4","author":"Idei","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.reth.2026.101162_bib60","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/1358863X231164659","article-title":"Clinical outcomes of chronic limb-threatening ischemia due to inflammatory nonatherosclerotic versus atherosclerotic etiologies undergoing revascularization","volume":"28","author":"Iida","year":"2023","journal-title":"Vasc Med"},{"issue":"2","key":"10.1016\/j.reth.2026.101162_bib61","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-0035-1547516","article-title":"Preliminary report of endovascular treatment for critical limb ischemia patients with connective tissue disease: case series and review of the literature","volume":"24","author":"Obara","year":"2015","journal-title":"Int J Angiol"},{"issue":"4","key":"10.1016\/j.reth.2026.101162_bib62","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s12928-025-01157-y","article-title":"Long-term outcomes of endovascular therapy for chronic limb-threatening ischemia patients with connective tissue disease","volume":"40","author":"Ouchi","year":"2025","journal-title":"Cardiovasc Interv Ther"},{"issue":"4","key":"10.1016\/j.reth.2026.101162_bib63","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1253\/circj.CJ-17-0510","article-title":"Long-term clinical outcomes survey of bone marrow-derived cell therapy in critical limb ischemia in Japan","volume":"82","author":"Kondo","year":"2018","journal-title":"Circ J"},{"issue":"3","key":"10.1016\/j.reth.2026.101162_bib64","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1253\/circj.CJ-18-1044","article-title":"Impact of therapeutic angiogenesis using autologous bone marrow-derived mononuclear cells implantation in critical limb ischemia with scleroderma - subanalysis of the long-term clinical outcomes survey","volume":"83","author":"Shoji","year":"2019","journal-title":"Circ J"},{"issue":"1","key":"10.1016\/j.reth.2026.101162_bib45","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13287-023-03390-9","article-title":"Report of a phase 1 clinical trial for safety assessment of human placental mesenchymal stem cells therapy in patients with critical limb ischemia (CLI)","volume":"14","author":"Shirbaghaee","year":"2023","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.reth.2026.101162_bib51","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ejvs.2024.09.005","article-title":"Leg ischemia management Collaboration. Streamlined clinical management pathways may reduce major amputations in patients with chronic limb threatening ischemia: a prospective cohort study with historical controls","volume":"69","author":"Houghton","year":"2025","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.reth.2026.101162_bib65","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/CLEP.S188752","article-title":"Randomized clinical trials with run-in periods: frequency, characteristics and reporting","volume":"11","author":"Laursen","year":"2019","journal-title":"Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.reth.2026.101162_bib66","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmacoepidemiology","volume":"167","author":"Suissa","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"23","key":"10.1016\/j.reth.2026.101162_bib67","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jcin.2021.08.079","article-title":"Objective outcome measures for trials in patients with chronic limb-threatening ischemia across 2 decades: analysis and recommendations","volume":"14","author":"Lakhter","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.reth.2026.101162_bib68","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s12015-021-10176-0","article-title":"Extracellular vesicles from human umbilical cord Mesenchymal stem cells facilitate diabetic wound healing through MiR-17-5p-mediated enhancement of angiogenesis","volume":"18","author":"Wei","year":"2022","journal-title":"Stem Cell Rev Rep"},{"issue":"3","key":"10.1016\/j.reth.2026.101162_bib69","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s12015-021-10164-4","article-title":"MSC-derived extracellular vesicles to heal diabetic wounds: a systematic review and meta-analysis of preclinical animal studies","volume":"18","author":"Bailey","year":"2022","journal-title":"Stem Cell Rev Rep"},{"issue":"5","key":"10.1016\/j.reth.2026.101162_bib70","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s12015-024-10712-8","article-title":"Understanding the angiogenic characteristics of clinical-grade mesenchymal stromal cells isolated from human umbilical cord","volume":"20","author":"Carcopino","year":"2024","journal-title":"Stem Cell Rev Rep"},{"issue":"4","key":"10.1016\/j.reth.2026.101162_bib71","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.reth.2026.101162_bib72","article-title":"Mesenchymal stromal cell-derived extracellular vesicles in regenerative medicine: standardization, bioengineering, and clinical translation","volume":"31","author":"Shimizu","year":"2026","journal-title":"Regen Ther"},{"issue":"5","key":"10.1016\/j.reth.2026.101162_bib73","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1007\/s12015-022-10373-5","article-title":"Industrialized GMP production of CD34+ cells (ProtheraCytes) at clinical scale for treatment of ischemic cardiac diseases is feasible and safe","volume":"18","author":"Henon","year":"2022","journal-title":"Stem Cell Rev Rep"},{"issue":"8","key":"10.1016\/j.reth.2026.101162_bib74","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1007\/s12015-024-10787-3","article-title":"Therapeutic applications of engineered mesenchymal stromal cells for enhanced angiogenesis in cardiac and cerebral ischemia","volume":"20","author":"Hegde","year":"2024","journal-title":"Stem Cell Rev Rep"}],"container-title":["Regenerative Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320426001033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320426001033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T09:39:03Z","timestamp":1794303543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352320426001033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":74,"alternative-id":["S2352320426001033"],"URL":"https:\/\/doi.org\/10.1016\/j.reth.2026.101162","relation":{},"ISSN":["2352-3204"],"issn-type":[{"value":"2352-3204","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host-state biomarkers and clinical factors for stratification and optimization of cell therapy trials in chronic limb-threatening ischemia: A review","name":"articletitle","label":"Article Title"},{"value":"Regenerative Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reth.2026.101162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier BV on behalf of The Japanese Society for Regenerative Medicine.","name":"copyright","label":"Copyright"}],"article-number":"101162"}}